Fragment-Based Screening of Heterocyclic Electrophiles Identified Acrylamide Bioisoteres for Covalent KRas^G12C Inhibitors.

Authors

Nikolett Péczka, Aaron Keeley, Péter Ábrányi-Balogh, Zoltán Orgován, László Petri, Emma K Grant, Chad Quinn, Soma Csanády, Ivan Randelovic, József Tóvári, Jacob Bush, György M Keserű

Published in

Archiv der Pharmazie. Volume 359. Issue 9. Pages e70342.

Abstract

Covalent fragment approaches gained increasing attention in medicinal chemistry. Our covalent heterocyclic fragment library (Covalent MiniFrags) consisting of five and six membered heterocycles was screened against the oncogenic target KRas^G12C. First, we detected the labeling of cysteine residues by Ellman's free thiol assay. Primary hits were characterized in a GSH reactivity assay and next we confirmed covalent labeling by RapidFire MS. Fragment hits with the best potential and selectivity were combined in silico with the quinazoline core of ARS-1620, and the best candidate was chosen for synthesis. Binding of the heterocyclic ARS derivative was confirmed via intact MS and HSQC NMR measurements. Its functional activity was characterized by nucleotide exchange assay and cell viability assay on cell lines expressing KRas^G12C. Our results support that screening of the heterocyclic electrophilic fragment library could provide viable chemical starting points for the development of targeted covalent inhibitors.

PMID:
42768907
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.